Bcr-Abl inhibitor Nilotinib monohydrochloride monohydrate, Purity ≥98%

Cat. No.: X24-06-ZQ484

Bcr-Abl inhibitor Nilotinib monohydrochloride monohydrate, Purity ≥98%

Synonym: 923288-90-8; Bcr-Abl inhibitor; AMN-107; Tasigna; AMN107

  • MDL: MFCD18251359
  • CAS Number: 923288-90-8
  • Compound CID: 16757572
Product Size
200 mg; 500 mg; 1 g
Price
Datasheet
MSDS
Properties
Description
Nilotinib monohydrochloride monohydrate specifically inhibits the activity of the Bcr-Abl tyrosine kinase.
Molecular Weight
583.99
Molecular Formula
C28H25ClF3N7O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Nilotinib monohydrochloride monohydrate targets Bcr-Abl for research in chronic myeloid leukemia therapies.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0